Omnicell

Omnicell, Inc.

Company type	Public
Industry	Healthcare technology
Founded	September 1992 (1992-09)
Founder	Randall A. Lipps
Headquarters	Mountain View, California , United States
Area served	Global
Key people	Patrick Lipps (CEO)
Products	Automated medication management solutions, medication adherence packaging, patient engagement software
Number of employees	3800 (2021)
Website	www.omnicell.com

Omnicell, Inc. is a global American healthcare technology firm based in Mountain View, CA. The company focuses on automated medication management solutions for hospitals and healthcare environments, as well as medication adherence packaging and patient engagement software tailored for retail pharmacies. Its products are distributed under the Omnicell and EnlivenHealth brands.

1992–1999

Omnicell was established in September 1992 by entrepreneur Randall A. Lipps, who was motivated by the difficulties nurses encountered obtaining medical supplies during his daughter's hospital stay. Partnering with graduate students from Stanford University, Lipps created an initial prototype that automated inventory management processes previously handled manually by nursing staff.

In 1993, under Lipps’s direction as chairman, the company began commercializing automated supply cabinets designed to monitor transaction records, inventory levels, costs, and patient billing information. By 1996, Omnicell had expanded its product range to include pharmacy automation systems for dispensing medications. The acquisition of Baxter Healthcare Corp.'s SureMed pharmacy cabinet line in 1999 further enhanced Omnicell’s market presence and competitive position within hospital automation solutions.

2000–2020

By the end of the 1990s, Omnicell had deployed over 14,000 automated dispensing cabinets across upwards of 1,300 healthcare institutions, generating sales of $50 million. The company transitioned to a public entity in August 2001 on Nasdaq under the ticker OMCL and adopted the name Omnicell, Inc.

In 2002, leadership shifted as Patrick Lipps took over as CEO from Sheldon D. Asher. Omnicell pursued growth through targeted acquisitions such as BCX Technology, Inc. in 2003, which brought wireless handheld barcode scanners to enhance pharmaceutical tracking capabilities. The acquisition of MTS Technologies introduced multi-dose blister card packaging to support medication adherence in retail pharmacy settings. Purchasing Aesynt Inc. added robotic pharmacy inventory management and IV compounding automation along with advanced pharmacy data analytics software. The addition of Ateb, Inc. incorporated patient engagement and communication technologies into Omnicell’s portfolio, culminating in the establishment of the EnlivenHealth business segment in 2020.

Acquisitions and partnerships

• 2012 – MTS Medication Technologies was acquired, a global leader in medication adherence packaging solutions.
• 2014 – SurgiChem Limited, a UK-based company, was purchased for £12 million cash.
• 2015 – Mach4 Pharma Systems from Germany, specializing in robotic dispensing technology, was acquired.
• 2015 – Formed a distribution partnership with Avantec to market Omnicell products within the UK.
• 2016 – Acquired Aesynt Inc. for $275 million, enhancing capabilities in central pharmacy robotics, IV compounding automation, and data analytics.
• 2016 – Ateb, Inc. and its Canadian affiliate were acquired to broaden pharmacy patient care services and medication synchronization offerings.
• 2017 – InPharmics, a Mississippi-based provider of advanced hospital pharmacy informatics solutions, was purchased.
• 2020 – The 340B Link business from Pharmaceutical Strategies Group (PSG) was acquired to expand software-enabled service portfolios.
• 2021 – Collaborated with Guy’s and St Thomas’ NHS Foundation Trust in London to create technology-driven inventory optimization and intelligence services.

These strategic acquisitions and collaborations have significantly expanded Omnicell’s product offerings and international footprint, strengthening its leadership position in healthcare automation and pharmacy management solutions.

Finances

Year	Revenue in million USD	Net Profit in million USD	EBITDA in million USD	Total Assets in million USD	Shareholders' Equity in million USD	Share Price in USD	Number of Employees
2011	246	10	25	362	283	17
2012	314	16	45	442	308	15
2013	381	24	56	493	349	26
2014	441	31	71	560	390	33
2015	485	31	71	579	402	31
2016	693	1	73	935	432	34
2017	716	21	61	980	517	49	2372
2018	787	38	100	1081	680	61	2501
2019	897	61	142	1241	845	82	2698
2020	892	32	117	1825	968	120	2862
2021	1132	78	230	2142	1147	180	3800